| 1 |
Holm K, Svensson PJ, Rasmussen M. Invasive Fusobacterium necrophorum infections and Lemierre’s syndrome: the role of thrombophilia and EBV Eur J Clin Microbiol Infect Dis. 2015; 34(11):2199-207.
doi: 10.1007/s10096-015-2469-8
|
| 2 |
Laurencet ME, Rosset-Zufferey S, Schrenzel J. Atypical presentation of Lemierre’s syndrome: case report and literature review. BMC Infect Dis. 2019; 19(1):868.
doi: 10.1186/s12879-019-4538-6
|
| 3 |
Valerio L, Zane F, Sacco C, Granziera S, Nicoletti T, Russo M, et al. Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases. J Intern Med. 2021; 289(3):325-39.
doi: 10.1111/joim.v289.3
|
| 4 |
Duan LW, Qu JL, Wan J, Xu YH, Shan Y, Wu LX, et al. Effects of viral infection and microbial diversity on patients with sepsis: a retrospective study based on metagenomic next-generation sequencing. World J Emerg Med. 2021; 12(1):29-35.
doi: 10.5847/wjem.j.1920-8642.2021.01.005
|
| 5 |
Riordan T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev. 2007; 20(4):622-59.
pmid: 17934077
|
| 6 |
Bondy P, Grant T. Lemierre’s syndrome: what are the roles for anticoagulation and long-term antibiotic therapy? Ann Otol Rhinol Laryngol. 2008; 117(9):679-83.
doi: 10.1177/000348940811700909
|
| 7 |
Nygren D, Holm K. Invasive infections with Fusobacterium necrophorum including Lemierre’s syndrome: an 8-year Swedish nationwide retrospective study Clin Microbiol Infect. 2020; 26(8):1089.e7-1089.e12.
doi: 10.1016/j.cmi.2019.12.002
|
| 8 |
Chaudhary H, Ramaswamy S, Qaiser Y, Zaman U, Miller R, McFarlane SI. Lemierre’s syndrome with severe thrombocytopenia without disseminated intravascular coagulation: a case report and literature review. Am J Med Case Rep. 2021; 9(3):158-62.
doi: 10.12691/ajmcr-9-3-7
pmid: 33681457
|
| 9 |
Wingfield T, Blanchard TJ, Ajdukiewicz KMB. Severe pneumonia and jaundice in a young man: an atypical presentation of an uncommon disease. J Med Microbiol. 2011; 60(Pt 9):1391-4.
doi: 10.1099/jmm.0.029942-0
pmid: 21546562
|
| 10 |
Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care. 1991; 19(2):165-81.
doi: 10.1177/0310057X9101900203
|
| 11 |
Stahlman GC, DeBoer DK, Green NE. Fusobacterium osteomyelitis and pyarthrosis: a classic case of Lemierre’s syndrome. J Pediatr Orthop. 1996; 16(4):529-32.
doi: 10.1097/01241398-199607000-00022
|
| 12 |
Fan YW, Jiang SW, Chen JM, Wang HQ, Liu D, Pan SM, et al. A pulmonary source of infection in patients with sepsis-associated acute kidney injury leads to a worse outcome and poor recovery of kidney function. World J Emerg Med. 2020; 11(1):18-26.
doi: 10.5847/wjem.j.1920-8642.2020.01.003
|
| 13 |
Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004; 32(Supplement):S495-512.
doi: 10.1097/01.CCM.0000143118.41100.14
|
)
